Episode 215
Episode 213: Arun Ananth and Tom Gallo - Data As An Asset With Proscia’s Diagnostic Network
August 18, 202535m 56s
Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Today my guests are Arun Ananth, CCO and Tom Gallo, CFO from Proscia.
What we discuss with Arun and Tom:
- Introduction to Proscia’s Diagnostic Network
- Reshaping the economics of pathology
- Economic opportunities in digital pathology
- Data as an asset in biomarker discovery
- Clinical trials as use cases
- Compliance and security in digital pathology
- Pathology's central role in treatment
- Accelerating digital adoption and ROI
- Patient benefits and clinical trials
- Risks and barriers in digital pathology
- Advice for labs considering digital pathology
- Market adoption and future vision
Links for this episode:
Pathologists' Assistant Shadowing Network
Proscia Cements Leadership in Diagnostic Pathology with 400% Growth in Daily Cases
Rewiring the Laboratory’s Bottom Line: Moving Towards Digital Pathology as a Profit Center
People of Pathology Podcast: